Hillstream BioPharma, Inc.
HILS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1 | $0 | $0 |
| - Cash | $8 | $2 | $1 | $4 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | -$2 | -$1 | -$3 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$3 | -$5 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$3 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.34 | -0.64 | -1.96 | -4.14 |
| % Growth | 46.9% | 67.3% | 52.7% | – |
| Operating Cash Flow | -$2 | -$1 | -$3 | -$5 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$1 | -$3 | -$5 |